CHICAGO and ATLANTA—August 13, 2010—Allscripts-Misys Healthcare Solutions (Allscripts), a provider of clinical software, information and connectivity solutions for physicians, and Eclipsys, a provider of solutions and services for hospitals and clinicians, today announced that stockholders of each company approved the merger of Allscripts and Eclipsys.
At the special meeting of Allscripts stockholders, held earlier today, 99 percent of the Allscripts shares voted were in favor of the issuance of Allscripts shares to stockholders of Eclipsys in the merger. At the special meeting of Eclipsys stockholders, also held earlier today, 99 percent of the Eclipsys shares voted approved the merger (representing 83 percent of the shares outstanding).
Under the terms of the merger agreement announced on June 9, 2010, Eclipsys stockholders will receive 1.2 shares of Allscripts for each share of Eclipsys. Allscripts and Eclipsys expect the transaction to be completed promptly after all other conditions to the merger are satisfied, including the completion of the sale of no less than 25 million shares of Allscripts common stock currently held by Misys plc in an underwritten public offering and the completion of Allscripts repurchase from Misys (or one or more of its subsidiaries) of 24.4 million shares of Allscripts common stock.
